// App-Quantinova.ai

: Health outcomes following engagement with a digital health tool GroHealth app amongst people with type 2 diabetes

Researchers

Presenter

  • Farah Abdelhameed

Principal Investigators

  • Elle Pearson

  • Petra Hanson

  • Thomas Barber

  • Arjun Panesar

  • Charlotte Summers

  • Michaela de la Fosse

Medical Centers

  • Warwickshire Institute for the Study of Diabetes, Warwick Medical School, University of Warwick, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom

  • Warwick Medical School, Univeristy of Warwick, Coventry, United Kingdom

  • Founding CEO and Head of AI, DDM Health Ltd, Coventry, United Kingdom

  • Founding Chief Operations Officer, DDM Health Ltd., Coventry, United Kingdom

  • Operations Manager, DDM Health Ltd., Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Prediabetes

Biomarkers

  • Aldo-keto Reductase Family 1 Member B10

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved